Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Related Articles by Review for PubMed (Select 21945327)

1.

Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N, Das P.

Trans R Soc Trop Med Hyg. 2011 Nov;105(11):661-6. doi: 10.1016/j.trstmh.2011.08.005. Epub 2011 Sep 25.

PMID:
21945327
2.

Recent advances in the diagnosis and treatment of kala-azar.

Sundar S, Chakravarty J.

Natl Med J India. 2012 Mar-Apr;25(2):85-9. Review.

PMID:
22686715
3.

Epidemiology of visceral leishmaniasis in India.

Bora D.

Natl Med J India. 1999 Mar-Apr;12(2):62-8. Review.

PMID:
10416321
4.

Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.

Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S.

J Assoc Physicians India. 2003 Jul;51:686-90. Review.

PMID:
14621038
5.

Visceral leishmaniasis in the New World & Africa.

Berman J.

Indian J Med Res. 2006 Mar;123(3):289-94. Review.

PMID:
16778311
6.

The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.

Bern C, Chowdhury R.

Indian J Med Res. 2006 Mar;123(3):275-88. Review.

PMID:
16778310
7.

Telehealth: a perspective approach for visceral leishmaniasis (kala-azar) control in India.

Bhunia GS, Kesari S, Chatterjee N, Kumar V, Das P.

Pathog Glob Health. 2012 Jul;106(3):150-8. doi: 10.1179/2047773212Y.0000000014. Review.

9.

Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.

Bhandari GP, Angdembe MR, Rijal S, Boelaert M.

Nepal Med Coll J. 2011 Sep;13(3):220-5. Review.

PMID:
22808821
10.

Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.

Ejazi SA, Ali N.

Expert Rev Anti Infect Ther. 2013 Jan;11(1):79-98. doi: 10.1586/eri.12.148. Review.

PMID:
23428104
11.

Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.

Joshi S, Rawat K, Yadav NK, Kumar V, Siddiqi MI, Dube A.

Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk